产品编号：F335410
产品规格：25mg
产品价格：面议
| 标准品编号: | F335410 |
| 名称: | 3’’’,5’’’-Dideshydroxy-3’’’,5’’’-dimethoxy Fidaxomicin |
| 别名: | (3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dimethoxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-oxacyclooctadeca-3,5,9,13,15-pentaen-2-one; 3''',5'''-Di-O-methyltiacumicin B |
| CAS号: | 185248-68-4 |
| 分子式: | C₅₄H₇₈Cl₂O₁₈ |
| 外观: | 白色至白色固体 |
| 熔点: | 130 - 134°C |
| 分子量: | 1086.09 |
| 储存: | -20°C Freezer, Under inert atmosphere |
| 溶解度: | Methanol (Slightly) |
| 种类: | Research Tools; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | 3’’’,5’’’-Dideshydroxy-3’’’,5’’’-dimethoxy Fidaxomicin is a derivative of Fidaxomicin (F335400), a nonabsorbed macrocyclic antibiotic, and is also the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. |
| 参考文献 | |
